Allist's Class III new generic formulation gets clinical trail approval from SFDA
Issue to：2006-5-22
The Allist's Class III new drug Duloxetine HCL and Duloxetine HCL enteric-coated tablet have successfully gotten clinical trail certification from SFDA.
